Sign in
4

Changes in Ownership

Monopar Therapeutics Filed Acc 0001437749-26-033024

Chief Executive Officer gave up 597 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Robinson Chandler · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-10-20 Shares withheld for taxes : show line 1 in the form −597 $92.59 $55,276 104,127 D
Loading xslF345X06/rdgdoc.xml…